Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)

Published:2018-01-18 Issue:6 Volume:110 Page:669-676
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Hershman Dawn L¹,Unger Joseph M²³⁴,Crew Katherine D¹,Till Cathee²³⁴,Greenlee Heather¹,Minasian Lori M⁴,Moinpour Carol M³,Lew Danika L²³,Fehrenbacher Louis⁵,Wade James L⁶,Wong Siu-Fun⁷,Fisch Michael J⁸,Lynn Henry N⁹,Albain Kathy S¹⁰

Affiliation:

1. Columbia University Medical Center, New York, NY

2. SWOG Statistical Center, Seattle, WA

3. Fred Hutchinson Cancer Research Center, Seattle, WA

4. Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD

5. Kaiser Permanente Northern California, Vallejo, CA

6. Central Illinois CCOP/Cancer Care Specialists of Central Illinois, Decatur, IL

7. Loma Linda University School of Pharmacy, Loma Linda, CA

8. AIM Specialty Health, Chicago, IL

9. Huntsman Cancer Institute, Salt Lake City, UT

10. Loyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, IL

Funder

Conquer Cancer Foundation

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/6/669/25041918/djx259.pdf

Reference26 articles.

1. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline;Hershman;J Clin Oncol.,2014

2. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy;Hershman;J Clin Oncol.,2013

3. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy;Hershman;Breast Cancer Res Treat.,2011

4. Weekly paclitaxel in the adjuvant treatment of breast cancer;Sparano;N Engl J Med.,2008

5. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer;Jones;J Clin Oncol.,2006

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221;Cancer Chemotherapy and Pharmacology;2024-05-30

2. Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions;Future Journal of Pharmaceutical Sciences;2024-05-06

3. Palliative and Supportive Medicine in Gastrointestinal Oncology;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

4. Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy;Supportive Care in Cancer;2023-12-22

5. Colon Cancer Survivorship in Patients Who Have Received Adjuvant Chemotherapy;Clinical Colorectal Cancer;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3